邁克生物(300463.SZ):參設產業基金完成備案手續
格隆匯6月29日丨邁克生物(300463.SZ)公吿,公司於2020年10月23日披露了《關於公司參與投資設立產業基金並簽署合作協議的公吿》,公司擬以自有資金出資人民幣5000萬元參與投資設立成都國生普華邁克股權投資基金合夥企業(有限合夥)(“產業基金”),產業基金首期認繳出資1.5億元,公司認繳750萬元,佔產業基金總規模的5%。產業基金已於2021年3月23日取得營業執照。
近日,公司收到通知,成都國生普華邁克股權投資基金合夥企業(有限合夥)已完成中國證券投資基金業協會備案手續,取得了《私募投資基金備案證明》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.